Pharming (PHAR) Operating Leases (2019 - 2026)
Pharming's Operating Leases was $11.85 million in Q2 2026, down 56.9% from $27.5 million a year earlier and down 19.2% from the prior quarter.
Powered by 
Analysis
Pharming (PHAR) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Operating Leases at Pharming came in at $14.35 million, down 46.8% from FY2024.
- Operating Leases has now declined for three consecutive years, though with a five-year compound annual growth rate of 11.8% (FY2020 to FY2025).
- In earlier years, Operating Leases was $26.97 million in FY2024 (-8.6%), $29.51 million in FY2023 (-1.1%), $29.84 million in FY2022 (+61.7%) and $18.46 million in FY2021 (+124.3%).
- The Q2 2026 figure marks the lowest quarterly Operating Leases since Q3 2022.
- Compared with a year earlier, Operating Leases has declined for three straight quarters, with an average decline of 20.8% over the last eight quarters.
- The best year-over-year quarter for Operating Leases over five years was Q2 2023 (growth of 82.0%); the worst was Q3 2022 (a decline of 99.9%).
- Per Business Quant data, PHAR's Operating Leases in the three quarters before Q2 2026 was $14.67 million (Q1 2026), $14.35 million (Q4 2025) and $28.09 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Pharming | 738.17 Mn | -91.99 Mn | 141.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.85 Mn |
| Mar 31, 2026 | 14.67 Mn |
| Dec 31, 2025 | 14.35 Mn |
| Sep 30, 2025 | 28.09 Mn |
| Jun 30, 2025 | 27.50 Mn |
| Mar 31, 2025 | 26.51 Mn |
| Dec 31, 2024 | 26.97 Mn |
| Sep 30, 2024 | 27.78 Mn |
| Jun 30, 2024 | 27.73 Mn |
| Mar 31, 2024 | 28.44 Mn |
| Dec 31, 2023 | 29.51 Mn |
| Sep 30, 2023 | 28.73 Mn |
| Jun 30, 2023 | 30.30 Mn |
| Mar 31, 2023 | 31.07 Mn |
| Dec 31, 2022 | 29.84 Mn |
| Sep 30, 2022 | 15,227.00 |
| Jun 30, 2022 | 16.65 Mn |
| Mar 31, 2022 | 17.90 Mn |
| Dec 31, 2021 | 18,628.42 |
| Sep 30, 2021 | 19.32 Mn |
API Access
Pharming Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();